UBS downgraded Agiliti from Buy to Neutral and set a new price target of $10.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/7/2024 | $10.00 | Buy → Neutral | UBS |
| 2/6/2024 | Sector Weight | KeyBanc Capital Markets | |
| 1/4/2024 | $23.00 | Buy | Craig Hallum |
| 11/14/2023 | $16.00 → $10.00 | Neutral → Buy | UBS |
| 9/5/2023 | $18.00 → $11.00 | Neutral → Underperform | BofA Securities |
| 8/24/2023 | $15.00 → $10.00 | Equal-Weight → Underweight | Morgan Stanley |
| 8/15/2023 | $20.00 → $13.00 | Buy → Neutral | Citigroup |
| 8/10/2023 | Outperform → Mkt Perform | Raymond James |
SC 13G - AGILITI, INC. \DE (0001749704) (Subject)
NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,
Tom Leonard returns as Chief Executive Officer Agiliti, Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that the Agiliti Board of Directors has appointed Tom Leonard as Chief Executive Officer. Leonard succeeds Tom Boehning who is no longer with the company. Leonard previously served as CEO of Agiliti from April 2015 until his retirement from the company in March 2023. He served as a member of the company's Board of Directors following his retirement and will remain a Board member as he returns to the role of CEO. "Tom Leonard led the company through eight years of profitable growth
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
15-12G - AGILITI, INC. \DE (0001749704) (Filer)
EFFECT - AGILITI, INC. \DE (0001749704) (Filer)
10-Q - AGILITI, INC. \DE (0001749704) (Filer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
4 - AGILITI, INC. \DE (0001749704) (Issuer)
UBS downgraded Agiliti from Buy to Neutral and set a new price target of $10.00
KeyBanc Capital Markets initiated coverage of Agiliti with a rating of Sector Weight
Craig Hallum initiated coverage of Agiliti with a rating of Buy and set a new price target of $23.00
DigitalOcean Holdings, Inc. (NYSE:DOCN) is set to release earnings results for its first quarter before the opening bell on May 10, 2024. Analysts expect the New York-based company to report quarterly earnings at 38 cents per share, up from 28 cents per share in the year-ago period. DigitalOcean is projected to report quarterly revenue of $182.58 million, compared to $165.13 million a year ago, according to data from Benzinga Pro. DigitalOcean replaced Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 on Tuesday, May 7. DigitalOcean shares fell 3.2% to close at $32.58 on Thursday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can
Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final condition
Raymond James analyst John Ransom maintains Agiliti (NYSE:AGTI) from Market Perform to Market Perform.
Agiliti Taken Private for $10.00 per Share in Cash Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"). On February 26, 2024, Agiliti announced that THL had signed a definitive agreement to purchase all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates or certain management and director shareholders for $10.00 per share, implying a total enterprise value of $2.5 billion. "The work we do at Agiliti has strengthened our nation's healthcar
NEW YORK, April 30, 2024 /PRNewswire/ -- DigitalOcean Holdings Inc. (NYSE:DOCN) will replace Agiliti Inc. (NYSE:AGTI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 7. Thomas H. Lee Partners L.P. is acquiring Agiliti in a deal expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 7, 2024 S&P SmallCap 600 Addition DigitalOcean Holdings DOCN Information Technology S&P SmallCap 600 Deletion Agiliti AGTI Health Care For more information about S&P Dow Jones Indices,
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea
Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of healthcare technology management and service solutions to the healthcare industry, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023 Highlights Revenue growth of 4% to $292 million Net loss of $5.7 million, compared to net income of $3.4 million in the prior year period; diluted loss per share of $0.04, compared to diluted earnings per share of $0.02 in the prior year period Adjusted EBITDA1 of $67.3 million, compared to $71.4 million in the prior year period; Adjusted Earnings Per Share1 of $0.13, compared to $0.18 in the prior year period Full-Yea
Unanimously Recommended by Special Committee of the Agiliti Board of Directors Agiliti Shareholders to Receive $10.00 per Share in Cash, Representing Premia of 39% and 43% Over Agiliti's 30-Day and 90-Day Volume Weighted Average Price Agiliti Inc. (NYSE:AGTI) ("Agiliti"), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P. ("THL"), the company's majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain
Agiliti Inc. (NYSE:AGTI) ("Agiliti") today announced that the company will release its fourth quarter and full year 2023 financial results after the market close on Tuesday, March 5, 2024, to be followed by a conference call at 5 p.m. Eastern Time on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0792 or for international callers, 1-201-689-8263. The passcode for the live call is 13743834. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13743834. The replay will be available until March 19, 2024. Interested inve